FBLG
FibroBiologics, Inc.
1.10$
-4.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.1% | -3.6% | -21.8% | +17.5% | +57.1% | -30.5% | +21.7% | -37.1% | +10.0% | -38.3% | +33.5% | |
| – | -15.6% | -3.2% | -27.0% | +25.9% | +73.6% | -34.4% | +9.1% | -48.5% | +21.2% | -54.2% | +101.4% | |
| – | -14.9% | -11.0% | -26.8% | +31.0% | +78.7% | -38.0% | +2.1% | -45.0% | +0.6% | -69.7% | +137.2% | |
| – | -14.9% | -11.0% | -26.8% | +31.0% | +78.7% | -38.0% | +2.1% | -45.0% | +0.6% | -69.7% | +137.2% | |
| – | +282.8% | +44.4% | -26.0% | -31.6% | +77.3% | -33.8% | +43.8% | -33.9% | -59.8% | -3.6% | -1.3% | |
| – | +598.9% | +52.3% | -27.6% | -34.1% | +90.6% | -35.5% | +33.5% | -38.7% | -73.8% | +4.0% | +21.0% | |
| – | +2.5% | +129.6% | -19.5% | -24.2% | +1,787.4% | -34.7% | +39.1% | -40.0% | -86.5% | +37.3% | -60.6% | |
| – | +76.1% | -43.6% | +48.4% | -2.4% | +128.8% | -47.5% | +27.1% | -40.6% | -11.6% | -10.1% | +114.2% | |
| – | -88.1% | -408.3% | – | – | -0.1% | -14.1% | -63.4% | -85.5% | +4,824.8% | -57.8% | +78.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.0% | -2.1% | +5.1% | +2.4% | +3.8% | +5.5% | +5.4% | +11.5% | +54.4% | +13.4% | +0.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.